![]() |
Volumn 31, Issue 3, 2001, Pages 947-958
|
The generation of LMP2a-specific cytotoxic T lymphocytes for the treatment of patients with Epstein-Barr virus-positive Hodgkin disease
|
Author keywords
CTL; Dendritic cell; Epstein Barr virus; Hodgkin disease; Immunotherapy
|
Indexed keywords
CATION;
CD4 ANTIGEN;
CD8 ANTIGEN;
EBNA1 PROTEIN;
EPSTEIN BARR VIRUS ANTIGEN;
HLA ANTIGEN CLASS 1;
HLA ANTIGEN CLASS 2;
LATENT MEMBRANE PROTEIN 1;
LATENT MEMBRANE PROTEIN 2A;
LIPID;
RNA;
UNCLASSIFIED DRUG;
ANTIGEN EXPRESSION;
ARTICLE;
ASSAY;
CELL GROWTH;
CELL SEPARATION;
CONTROLLED STUDY;
CYTOTOXIC T LYMPHOCYTE;
CYTOTOXICITY;
DENDRITIC CELL;
DONOR;
EPSTEIN BARR VIRUS;
GENETIC TRANSFECTION;
HODGKIN DISEASE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
IMMUNOPHENOTYPING;
IMMUNOREACTIVITY;
IMMUNOSTIMULATION;
IMMUNOTHERAPY;
IN VITRO STUDY;
LYMPHOBLASTOID CELL LINE;
LYMPHOPROLIFERATIVE DISEASE;
MIXED LYMPHOCYTE REACTION;
NASOPHARYNX CARCINOMA;
PRIORITY JOURNAL;
PROPHYLAXIS;
SERUM;
T LYMPHOCYTE SUBPOPULATION;
TUMOR CELL;
ANTIGENS, VIRAL;
CD4-POSITIVE T-LYMPHOCYTES;
CELL LINE;
CELLS, CULTURED;
CYTOTOXICITY TESTS, IMMUNOLOGIC;
DENDRITIC CELLS;
EPSTEIN-BARR VIRUS INFECTIONS;
HERPESVIRUS 4, HUMAN;
HODGKIN DISEASE;
HUMANS;
IMMUNOPHENOTYPING;
LYMPHOCYTE ACTIVATION;
T-LYMPHOCYTES, CYTOTOXIC;
TRANSFECTION;
VIRAL MATRIX PROTEINS;
|
EID: 0035085460
PISSN: 00142980
EISSN: None
Source Type: Journal
DOI: 10.1002/1521-4141(200103)31:3<947::AID-IMMU947>3.0.CO;2-M Document Type: Article |
Times cited : (63)
|
References (31)
|